Medical Research
(H30)
SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$332K
Total Revenue
$238K
Total Expenses
$1.1M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
76.7%
Fundraising Efficiency
0.0%
Operating Reserve
54.11x
Liability-to-Asset
3.0%
Revenue Diversification
100.0%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $332K | $238K | $1.1M | 76.7% | 0 |
| 2022 | $627K | $184K | N/A | — | 0 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.